eculizumab April 12, 2017 eculizumab Trade Name Orphan Indication Idiopathic membranous glomerular nephropathy USA Market Approval USA USA Designation Date 2001-03-05 00:00:00 Sponsor Alexion Pharmaceuticals, Inc.;352 Knotter Drive;Cheshire, Connecticut, 06410
